Guardian Pharmacy Services, Inc.’s (NYSE:GRDN) Lock-Up Period Will End Tomorrow

Guardian Pharmacy Services’ (NYSE:GRDN) lock-up period is set to end on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its initial public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. After the expiration of Guardian Pharmacy Services’ lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Guardian Pharmacy Services Stock Down 1.3 %

NYSE:GRDN opened at $21.36 on Monday. Guardian Pharmacy Services has a 1 year low of $14.16 and a 1 year high of $25.74. The firm has a 50-day simple moving average of $20.55.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several institutional investors and hedge funds have recently modified their holdings of GRDN. Maven Securities LTD bought a new stake in Guardian Pharmacy Services during the 3rd quarter worth approximately $3,033,000. Point72 DIFC Ltd acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth $573,000. Wellington Management Group LLP acquired a new stake in shares of Guardian Pharmacy Services during the third quarter worth $8,400,000. Barclays PLC bought a new stake in Guardian Pharmacy Services in the 3rd quarter valued at $311,000. Finally, Virtu Financial LLC bought a new stake in Guardian Pharmacy Services in the 3rd quarter valued at $279,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.